Side-to-side mesocaval shunt in portal hypertension.
Eighty-five consecutive patients underwent side-to-side mesocaval shunt with a success rate of 98.8% and a 30-day hospital mortality of 2.4%. Eighty cases were followed up for three months to eight years, eight died, encephalopathy occurred in three (4.3%), rebleeding in five, ascites in two and lower leg edema in three. A long history of hepatitis and impairment of liver function were the common features of dying patients. The rebleeding rate was 8.5%. Liver function had a significant influence on the outcome of treatment.